Heron Therapeutics Analyst Ratings
BenzingaApr 23 19:10
Capital One Initiates Coverage On Heron Therapeutics With Overweight Rating, Announces Price Target of $6
BenzingaApr 23 19:14
Heron Therapeutics Analyst Ratings
BenzingaApr 11 18:00
Needham Reiterates Buy on Heron Therapeutics, Maintains $5 Price Target
BenzingaApr 11 18:02
Northland Securities Keeps Their Buy Rating on Heron Therapeutics (HRTX)
TipRanksMar 13 20:56
Heron Therapeutics Analyst Ratings
BenzingaMar 13 18:26
Needham Maintains Buy on Heron Therapeutics, Raises Price Target to $5
BenzingaMar 13 18:28
Heron Therapeutics (HRTX) Gets a Buy From Northland Securities
TipRanksJan 5 22:15
Needham Maintains Buy on Heron Therapeutics, Lowers Price Target to $4
BenzingaNov 15, 2023 20:49
Heron Therapeutics Analyst Ratings
BenzingaNov 15, 2023 20:47
Analysts Offer Insights on Healthcare Companies: Asensus Surgical (ASXC), Cue Health (HLTH) and Heron Therapeutics (HRTX)
TipRanksNov 15, 2023 19:30
Needham Reiterates Buy on Heron Therapeutics, Maintains $5 Price Target
BenzingaAug 15, 2023 18:33
Heron Therapeutics Analyst Ratings
BenzingaAug 15, 2023 18:33
Needham Adjusts Price Target on Heron Therapeutics to $5 From $6, Maintains Buy Rating
MT NewswiresJul 25, 2023 18:45
Needham Maintains Buy on Heron Therapeutics, Lowers Price Target to $5
BenzingaJul 25, 2023 16:13
Heron Therapeutics Analyst Ratings
BenzingaJul 25, 2023 16:13
Heron Therapeutics (HRTX) Gets a Buy From Needham
TipRanksApr 21, 2023 20:32
Needham Reiterates Buy on Heron Therapeutics, Maintains $7 Price Target
BenzingaApr 21, 2023 18:59
Evercore ISI Group Maintains Outperform on Heron Therapeutics, Lowers Price Target to $10
BenzingaMar 24, 2023 23:56
Analysts Offer Insights on Healthcare Companies: Heron Therapeutics (HRTX), Monopar Therapeutics Inc (MNPR) and Werewolf Therapeutics (HOWL)
TipRanksMar 24, 2023 20:37
No Data
No Data